VolitionRx Statistics
Share Statistics
VolitionRx has 103.02M
shares outstanding. The number of shares has increased by 15.72%
in one year.
| Shares Outstanding | 103.02M |
| Shares Change (YoY) | 15.72% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 21.27% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,500 |
| FTD / Avg. Volume | 1.11% |
Short Selling Information
The latest short interest is 346.72K, so 0.34% of the outstanding
shares have been sold short.
| Short Interest | 346.72K |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 1.68 |
Valuation Ratios
The PE ratio is -1.93 and the forward
PE ratio is -9.88.
VolitionRx's PEG ratio is
0.05.
| PE Ratio | -1.93 |
| Forward PE | -9.88 |
| PS Ratio | 42.09 |
| Forward PS | 0.2 |
| PB Ratio | -2.08 |
| P/FCF Ratio | -1.98 |
| PEG Ratio | 0.05 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for VolitionRx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.52,
with a Debt / Equity ratio of -0.23.
| Current Ratio | 0.52 |
| Quick Ratio | 0.52 |
| Debt / Equity | -0.23 |
| Debt / EBITDA | -0.23 |
| Debt / FCF | -0.22 |
| Interest Coverage | -79.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $14,511.89 |
| Profits Per Employee | $-317,268.66 |
| Employee Count | 85 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -27.73% in the
last 52 weeks. The beta is 1, so VolitionRx's
price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -27.73% |
| 50-Day Moving Average | 0.5 |
| 200-Day Moving Average | 0.61 |
| Relative Strength Index (RSI) | 52.47 |
| Average Volume (20 Days) | 226,088 |
Income Statement
In the last 12 months, VolitionRx had revenue of 1.23M
and earned -26.97M
in profits. Earnings per share was -0.31.
| Revenue | 1.23M |
| Gross Profit | -68.72K |
| Operating Income | -27.02M |
| Net Income | -26.97M |
| EBITDA | -25.62M |
| EBIT | -26.92M |
| Earnings Per Share (EPS) | -0.31 |
Full Income StatementBalance Sheet
The company has 3.26M in cash and 5.82M in
debt, giving a net cash position of -2.56M.
| Cash & Cash Equivalents | 3.26M |
| Total Debt | 5.82M |
| Net Cash | -2.56M |
| Retained Earnings | -229.54M |
| Total Assets | 8.52M |
| Working Capital | -4.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -25.89M
and capital expenditures -277.5K, giving a free cash flow of -26.17M.
| Operating Cash Flow | -25.89M |
| Capital Expenditures | -277.5K |
| Free Cash Flow | -26.17M |
| FCF Per Share | -0.3 |
Full Cash Flow StatementMargins
Gross margin is -5.57%, with operating and profit margins of -2190.9% and -2186.27%.
| Gross Margin | -5.57% |
| Operating Margin | -2190.9% |
| Pretax Margin | -2209.79% |
| Profit Margin | -2186.27% |
| EBITDA Margin | -2076.62% |
| EBIT Margin | -2190.9% |
| FCF Margin | -2121.68% |
